Art et Cognition - Dana Foundation

96
20 Parkinson Study Group. A controlled, randomized, delayed-start study of rasagiline in early
Parkinson disease. Archives of Neurology. 2004 61(4):561-566.
21 Voir note 4.
22 Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson’s disease
caused by mutations in PINK1. Science. 2004 304(5674):1158-1160.
23 Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset
parkinsonism. Annals of Neurology. 2004 56(3):336-341.
24 Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in
parkin-deficient mice. Journal of Biological Chemistry. 2004 279(18):18614-18622.
25 Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy:
evidence in mice and man. Experimental Neurology. 2004 185(2):232-240.
26 Voir note 7.
27 Nikulina E, Tidwell JL, Dai HN, et al. The phosphodiesterase inhibitor rolipram delivered after a
spinal cord lesion promotes axonal regeneration and functional recovery. Proceedings of the
National Academy of Sciences USA. 2004 101(23): 8786-8790.
28 Lu P, Yang H, Jones LL, et al. Combinatorial therapy with neurotrophins and cAMP promotes
axonal regeneration beyond sites of spinal cord injury. Journal of Neuroscience. 2004 24(28):
6402-6409.
29 Bhatt DH, Otto SJ, Depoister B, et al. Cyclic AMP-induced repair of zebrafish spinal circuits.
Science. 2004 305(5681):254-258.
30 Harper JM, Krishnan C, Darman JS, et al. Axonal growth of embryonic stem cell-derived motoneurons
in vitro and in motoneuron-injured adult rats. Proceedings of the National Academy of
Sciences USA. 2004 101(18):7123-7128.
31 Zhu DY, Lau L, Liu SH, et al. Activation of cAMP-response-elementbinding protein (CREB) after
focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proceedings of the
National Academy of Sciences USA. 2004 101(25):9453-9457.
32 Davies JE, Tang X, Denning JW, et al. Decorin suppresses neurocan, brevican, phosphacan and
NG2 expression and promotes axon growth across adult rat spinal cord injuries. European
Journal of Neuroscience. 2004 19(5):1226-1242.
33 Lee JK, Kim JE, Sivula M, et al. Nogo receptor antagonism promotes stroke recovery by enhancing
axonal plasticity. Journal of Neuroscience. 2004 24(27):6209-6217.
34 Li W, Walus L, Rabacchi SA, et al. A neutralizing anti-Nogo66 receptor monoclonal antibody
reverses inhibition of neurite outgrowth by central nervous system myelin. Journal of Biological
Chemistry. 2004 279(42):43780-43788.
35 Fischer D, He Z, Benowitz LI. Counteracting the Nogo receptor enhances optic nerve regeneration
if retinal ganglion cells are in an active growth state. Journal of Neuroscience. 2004
24(7):1646-1651.
36 Voir note 9.
37 Voir note 8.
38 Michels R, Cohen JD. Neuroscience, neuropsychiatry and neuroethics: an overview. (Jan. 15, 2004):
http://bioethicsprint.bioethics.gov/transcripts/jan04/session3.html.
39 Society for Neuroscience. Strategic Initiatives for 2003-2004: Professional Development and
Training. Society for Neuroscience Annual Progress Report (2003-2004): goal area #1.8.
40 Farah MJ, Wolpe PR. Monitoring and manipulating gene function. Hastings Center Report, 2004
34(3):35-45.